Related references
Note: Only part of the references are listed.Myeloid-derived suppressor cell heterogeneity in human cancers
Samantha Solito et al.
YEAR IN IMMUNOLOGY: MYELOID CELLS AND INFLAMMATION (2014)
Signaling pathways involved in MDSC regulation
Prashant Trikha et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2014)
The role of EPH receptors in cancer-related epithelial-mesenchymal transition
Rui-Xin Li et al.
CHINESE JOURNAL OF CANCER (2014)
Epstein-Barr virus and nasopharyngeal carcinoma
Lawrence S. Young et al.
CHINESE JOURNAL OF CANCER (2014)
A miR-151 binding site polymorphism in the 3′-untranslated region of the cyclin El gene associated with nasopharyngeal carcinoma
Ying Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Fibrocytes represent a novel MDSC subset circulating in patients with metastatic cancer
Hua Zhang et al.
BLOOD (2013)
Melanoma-Educated CD14+ Cells Acquire a Myeloid-Derived Suppressor Cell Phenotype through COX-2-Dependent Mechanisms
Yumeng Mao et al.
CANCER RESEARCH (2013)
Myeloid-Derived Suppressor Cells Enhance Stemness of Cancer Cells by Inducing MicroRNA101 and Suppressing the Corepressor CtBP2
Tracy X. Cui et al.
IMMUNITY (2013)
Cancer-Related Inflammation
Juliana Candido et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2013)
Induction of myelodysplasia by myeloid-derived suppressor cells
Xianghong Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Down-regulation of PLCγ2-β-catenin pathway promotes activation and expansion of myeloid-derived suppressor cells in cancer
Aude-Helene Capietto et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Myeloid-Derived Suppressor Cells Suppress Antitumor Immune Responses through IDO Expression and Correlate with Lymph Node Metastasis in Patients with Breast Cancer
Jinpu Yu et al.
JOURNAL OF IMMUNOLOGY (2013)
Blood CD33(+)HLA-DR(-) myeloid-derived suppressor cells are increased with age and a history of cancer
Chris P. Verschoor et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
Expansion of Monocytic Myeloid-Derived Suppressor Cells Dampens T Cell Function in HIV-1-Seropositive Individuals
Aiping Qin et al.
JOURNAL OF VIROLOGY (2013)
Locoregional radiotherapy in patients with distant metastases of nasopharyngeal carcinoma at diagnosis
Ming-Yuan Chen et al.
CHINESE JOURNAL OF CANCER (2013)
Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients
Paola Filipazzi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Wnt/Snail Signaling Regulates Cytochrome c Oxidase and Glucose Metabolism
Su Yeon Lee et al.
CANCER RESEARCH (2012)
T-Regulatory Cells: Key Players in Tumor Immune Escape and Angiogenesis
Andrea Facciabene et al.
CANCER RESEARCH (2012)
Apricoxib, a Novel Inhibitor of COX-2, Markedly Improves Standard Therapy Response in Molecularly Defined Models of Pancreatic Cancer
Amanda Kirane et al.
CLINICAL CANCER RESEARCH (2012)
Myeloid Cells Obtained from the Blood but Not from the Tumor Can Suppress T-cell Proliferation in Patients with Melanoma
Alena Gros et al.
CLINICAL CANCER RESEARCH (2012)
Tumor suppressor dual-specificity phosphatase 6 (DUSP6) impairs cell invasion and epithelial-mesenchymal transition (EMT)-associated phenotype
Victor Chun Lam Wong et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Myeloid-derived suppressor cells from tumor-bearing mice impair TGF-β-induced differentiation of CD4+CD25+FoxP3+ Tregs from CD4+CD25-FoxP3- T cells
Sara M. Centuori et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2012)
Celecoxib inactivates epithelial-mesenchymal transition stimulated by hypoxia and/or epidermal growth factor in colon cancer cells
Claudia Bocca et al.
MOLECULAR CARCINOGENESIS (2012)
TGF-β-induced epithelial-mesenchymal transition: A link between cancer and inflammation
Jonas Fuxe et al.
SEMINARS IN CANCER BIOLOGY (2012)
Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression
Suzanne Ostrand-Rosenberg et al.
SEMINARS IN CANCER BIOLOGY (2012)
Ex vivo expansion of tumor-infiltrating lymphocytes from nasopharyngeal carcinoma patients for adoptive immunotherapy
Jia He et al.
CHINESE JOURNAL OF CANCER (2012)
Role of chemotherapy in stage IIb nasopharyngeal carcinoma
Xin-Bin Pan et al.
CHINESE JOURNAL OF CANCER (2012)
Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells
Natasa Obermajer et al.
BLOOD (2011)
PGE2-Induced CXCL12 Production and CXCR4 Expression Controls the Accumulation of Human MDSCs in Ovarian Cancer Environment
Natasa Obermajer et al.
CANCER RESEARCH (2011)
COX-2 Blockade Suppresses Gliomagenesis by Inhibiting Myeloid-Derived Suppressor Cells
Mitsugu Fujita et al.
CANCER RESEARCH (2011)
CpG Blocks Immunosuppression by Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice
Christine Zoglmeier et al.
CLINICAL CANCER RESEARCH (2011)
Myeloid derived suppressor cells in human diseases
Tim F. Greten et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2011)
Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice
Tangying Lu et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Phase I clinical trial of nasopharyngeal radiotherapy and concurrent celecoxib for patients with locoregionally advanced nasopharyngeal carcinoma
Wei-Ping Xue et al.
ORAL ONCOLOGY (2011)
Mesenchymal Transition and Dissemination of Cancer Cells Is Driven by Myeloid-Derived Suppressor Cells Infiltrating the Primary Tumor
Benjamin Toh et al.
PLOS BIOLOGY (2011)
The prevalence and prevention of nasopharyngeal carcinoma in China
Su-Mei Cao et al.
Chinese Journal of Cancer (2011)
URG11 mediates hypoxia-induced epithelial-to-mesenchymal transition by modulation of E-cadherin and beta-catenin
Rui Du et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Verification of the susceptibility loci on 7p12.2, 10q21.2, and 14q11.2 in precursor B-cell acute lymphoblastic leukemia of childhood
Rashmi B. Prasad et al.
BLOOD (2010)
Duffy antigen receptor for chemokines (Darc) polymorphism regulates circulating concentrations of monocyte chemoattractant protein-1 and other inflammatory mediators
Renate B. Schnabel et al.
BLOOD (2010)
Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells
Fanny Chalmin et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Characterization of Cytokine-Induced Myeloid-Derived Suppressor Cells from Normal Human Peripheral Blood Mononuclear Cells
Melissa G. Lechner et al.
JOURNAL OF IMMUNOLOGY (2010)
Inflammation and EMT: an alliance towards organ fibrosis and cancer progression
Jose Miguel Lopez-Novoa et al.
EMBO MOLECULAR MEDICINE (2009)
Regulatory T cells and EBV associated malignancies
Jiang Li et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2009)
Induction of myeloid-derived suppressor cells by tumor exosomes
Xiaoyu Xiang et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Weak expression of cyclooxygenase-2 is associated with poorer outcome in endemic nasopharyngeal carcinoma: analysis of data from randomized trial between radiation alone versus concurrent chemo-radiation (SQNP-01)
Susan Li Er Loong et al.
RADIATION ONCOLOGY (2009)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity
Kiavash Movahedi et al.
BLOOD (2008)
Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein
Pingyan Cheng et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
COX-2 expression predicts prostate-cancer outcome: analysis of data from the RTOG 92-02 trial
Li-Yan Khor et al.
LANCET ONCOLOGY (2007)
Pathways mediating the expansion and immunosuppressive activity of myeloid-derived suppressor cells and their relevance to cancer therapy
James E. Talmadge
CLINICAL CANCER RESEARCH (2007)
Twist and epithelial-mesenchymal transition are induced by the EBV oncoprotein latent membrane protein 1 and are associated with metastatic nasopharyngeal carcinoma
Toshiyuki Horikawa et al.
CANCER RESEARCH (2007)
Celecoxib reduces microvessel density in patients treated with nasopharyngeal carcinoma and induces changes in gene expression
R. A. Soo et al.
ANNALS OF ONCOLOGY (2006)
Intratumoral Cox-2 gene expression is a predictive factor for colorectal cancer response to fluoropyrimidine-based chemotherapy
K Uchida et al.
CLINICAL CANCER RESEARCH (2005)
Cyclooxygenases in cancer: progress and perspective
S Zha et al.
CANCER LETTERS (2004)
A role for cyclooxygenase-2 inhibitors in the prevention and treatment of cancer
LR Howe et al.
SEMINARS IN ONCOLOGY (2002)
Share Paper
